Abstract:Background To identify patients in whom systematic lymph node dissection would be suitable, preoperative diagnosis of the biological invasiveness of lung adenocarcinomas through the classification of these T1aN0M0 lung adenocarcinomas into several subgroups may be warranted. In this retrospective study, we sought to determine predictive factors of lymph node status in clinical stage T1aN0M0 lung adenocarcinomas. Methods We retrospectively reviewed the records of 273 consecutive patients undergone surgical resection of clinical stage T1aN0M0 lung adenocarcinomas at Shanghai Chest Hospital, from January 2011 to December 2012. Preoperative computed tomography findings of all 273 patients were reviewed and their tumors categorized as pure GGO, GGO with minimal solid components (<5 mm), part-solid (solid parts >5 mm), or purely solid. Relevant clinicopathologic features were investigated to identify predictors of hilar or mediastinal lymph node metastasis using univariate or multiple variable analysis. Results Among the 273 eligible clinical stage T1aN0M0 lung adenocarcinomas examined on thin-section CT, 103 (37.7%) were pure GGO, 118 (43.2%) GGO with minimal solid components, 13 (4.8%) part-solid (solid parts >5 mm, five GGO predominant and eight solid predominant), and 39 (14.3%) pure solid. There were 18 (6.6%) patients with lymph node metastasis. Incidence of N1 and N2 nodal involvement was 11 (6.6%) and seven (2.6%) patients, respectively. All patients with pure GGO and GGO with minimal solid components (<5 mm) tumors were pathologically staged N0. Multivariate analyses showed that the following factors significantly predicted lymph node metastasis for T1a lung adenocarcinomas: symptoms at presentation, GGO status, and abnormal carcinoembryonic antigen (CEA) titer. Multivariate analyses also showed that the following factors significantly predicted lymph node metastasis for pure solid tumors: air bronchogram sign, tumor size, symptoms at presentation, and abnormal CEA titer. Conclusions The patients of clinical stage T1aN0M0 lung adenocarcinomas with pure GGO and GGO with minimal solid components tumors were pathologically staged N0 and systematic lymph node dissection should be avoided. But systematic lymph node dissection should be performed for pure solid tumors or part-solid, especially in patients with CEA greater than 5 ng/mL or symptoms at presentation, because of the high possibility of lymph node involvement.

Analysis of Risk Factors for Lymph Node Metastasis in Thoracic Cavity of Squamous Cell Lung Cancer and Adenocarcinoma

Incidence and Risk Factors of Lymph Node Metastasis in Breast Cancer Patients Without Preoperative Chemoradiotherapy and Neoadjuvant Therapy: Analysis of SEER Data.

Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational study.

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

Risk Analyses of N2 Lymph-Node Metastases in Patients with T1 Non-Small Cell Lung Cancer: a Multi-Center Real-World Observational Study in China

[Analysis of the Relationship Between Clinicopathological Features and Pelvic Lymph Node Metastasis in Patients with Early Stage Squamous Cell Carcinoma of the Uterine Cervix].

Clinical Analysis on Lymph Node Metastases of Thoracic Esophageal Squamous Cell Carcinoma

Risk Factors of Lymph Node Metastasis in Patients with Non‐small Cell Lung Cancer ≤ 2 Cm in Size: A Monocentric Population‐based Analysis

Factors Predicting Lymph Node Metastasis in Clinical Stage T1aN0M0 Lung Adenocarcinomas

Risk Factors for Lymph Node Metastasis in Submucosally Invasive Colorectal Cancer

[Correlation Analysis Between Imaging Features and Lymph Node Metastasis in T1a Lung Adenocarcinoma].

Factors That Predict Lymph Node Status in Clinical Stage T1aN0M0 Lung Adenocarcinomas

A Real-World Observational Study To Explore Clinical Characteristics Of Chinese Patients With T1 Non-Small Cell Lung Cancer Complicated With Lymph Metastases.

Distinct Lymph Node Metastasis Patterns Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Analysis of Pathological Risk Factors for Lymph Node Metastasis in Colorectal Cancer.

Lymph Node Metastasis Risk Factors in Clinical Stage IA3 Lung Adenocarcinoma.

Correlation Factors of N1 Lymph Node Metastasis in Patients with Lung Adenocarcinoma

Predictors of nodal metastasis and prognostic significance of lymph node ratio and total lymph node count in tracheobronchial adenoid cystic carcinoma.

[Analysis of Risk Factors Associated with Lymph Node Metastasis and Prognosis of T1-2 Colorectal Cancer].

Risk Factors for Cervical Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma: A Retrospective Population–Based Study

Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis